Latest Neuren Pharmaceuticals (ASX:NEU) News
Page 1
Page 1 of 5
Market Wrap - Week 45 (2 Nov -> 6 Nov) 2026
7 Nov 2026
Neuren upgrades trofinetide income guidance after DAYBUE sales jump
5 Nov 2026
Neuren wins FDA orphan designation for NNZ-2591 in neonatal brain injury
2 Nov 2026
Healthcare Wrap - Week 40 (28 Sept -> 2 Oct) 2026
3 Oct 2026
Neuren secures potential five-year extension to trofinetide patent protection
29 Sept 2026
Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
Neuren’s Royalties Climb as Profit Dips Amid Phase 3 Push and Dividend Debut
26 Aug 2026
European Commission Approves DAYBU for Rett Syndrome, Unlocking Milestone Payments for Neuren
25 Aug 2026
Market Wrap - Week 32 (3 Aug -> 7 Aug) 2026
8 Aug 2026
Healthcare Wrap - Week 32 (3 Aug -> 7 Aug) 2026
8 Aug 2026
Neuren’s DAYBUE Sales Surge 30% in Q2, Lifting 2026 Royalty Forecast
5 Aug 2026
Market Wrap - Week 27 (29 June -> 3 July) 2026
4 July 2026